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Background: Schistosoma haematobium infection is associated with urogenital morbidity. There 29 
are limited studies reporting on Schistosoma. haematobium infected pre-school age children, 30 
particularly concerning the extent of morbidity. In this study we investigated Schistosoma. 31 
haematobium morbidity in infected pre-school age children and established their disease burden.  32 
 33 
Methodology: Pre-school age children (1-5years) who were lifelong residents of the study area and 34 
had no other infections were included in the study. Participants underwent a physical examination 35 
with clinicians blinded from their infection status. Diagnosis of Schistosoma. haematobium was by 36 
urine filtration. 37 
 38 
Results: The prevalence of Schistosoma. haematobium was 35.1%(146/416). The clinical features 39 
observed in patients with Schistosoma. haematobium were: wheezes (morbidity attributable factor 40 
(AF=93.9%), haematuria (AF=92.6%), ascites (AF=91.5%), atopy (AF=76.9%), inguinal 41 
lymphadenopathy(AF=68.4%), stunting (AF=38.2) , malnutrition (MUAC)(AF=20%) and weight 42 
for height scales (AF=5%). Schistosoma. haematobium infected children were at greater odds ratio 43 
of presenting with inguinal lymphadenopathy (AOR)=99.2(95% CI 24.2 to 854.5), wheezes in the 44 
chest (AOR=35.4 95% CI 15.3 to 94.2), Distended abdomen with ascites (AOR=23.9 95% CI 11.4 45 
to 54), haematuria (AOR=12.6 95% CI 11.6 to 14.1), atopy history (AOR=5.6 95% CI 1.85 to 20.2), 46 
malnutrition (AOR=2.3 95% CI 1.4 to 3.2) and stunting (AOR= 1.9 95% CI 1.1 to2.7). 47 
 48 
Conclusion: The study is novel as it demonstrates for the first time clinical morbidity markers 49 
associated with Schistosoma. haematobium infection in pre-school age children. Furthermore the 50 
study adds scientific evidence to the call for inclusion of pre-school age children in schistosomiasis 51 
control programs. These morbidity markers highlight the need for early diagnosis and screening for 52 
S. haematobium in preschool age children. 53 
 54 
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Schistosomiasis is a neglected tropical disease and the 2nd most important parasitic disease in sub-64 
Saharan Africa (1). There are five species of the trematodes that affect humans. These are 65 
Schistosoma intercalatum, Schistosoma mekongi, Schistosoma japonicum, Schistosoma 66 
haematobium and Schistosoma mansoni. S. mansoni and S. japonicum are responsible for intestinal 67 
schistosomiasis, while S. haematobium causes urinary schistosomiasis (2). In Zimbabwe the 68 
common species are S. haematobium and S. mansoni (3) with former being highly prevalent is many 69 
areas.  Schistosomiasis morbidity has been extensively studied in adults and school aged children, 70 
but very little has been done on preschool age children (PSAC) (4–8). It has been noted that 71 
morbidity is directly proportional to infection intensity(5). Whereas the frequency of infection in 72 
PSAC has been presumed to be low, it is apparent that this is the age when infection begins (3).  73 
Unlike all the other neglected tropical diseases that had their disability-adjusted life years (DALYs) 74 
lowered during the period 1990 to 2010, DALY for schistosomiasis has increased by 55.7% (9). 75 
Schistosomiasis affects people residing in poverty-stricken areas for up to half of their lives . The 76 
new global interest to eliminate schistosomiasis as a public health problem by 2025 (65th WHA, 77 
2012) advocates targeting school age children (SAC) (10), while neglecting preschool age children 78 
(PSAC), due to assumed lack of exposure to infection.  79 
An estimated 50 million PSAC need treatment but fail to access it because they are excluded from 80 
national schistosomiasis control programs (11). PSAC are neglected because of difficulties in 81 
obtaining parasitology for diagnosis, difficulties in detecting light infections and inadequate 82 
knowledge about risk factors associated with the infection in this age group. It is usually assumed 83 
that the impact of schistosomiasis on health and associated morbidities in this age group are 84 
negligible (11). Another  main reason for excluding the PSAC is because of the lack of a paediatric 85 
dose formulation of praziquantel (12). The first encounter with schistosomiasis occurs during the 86 
first five years of life (13). This infection then persists, leading to a natural immune system change 87 
and increasing morbidity and risk of co-infections; as well as affecting cognition and growth (11). In 88 
this article we focus on S. haematobium which is highly prevalent in Zimbabwe, and determine the 89 
infection burden in a neglected group which is excluded in mass treatment campaigns. 90 
Trapped eggs in the human body systems causes much of the morbidity (14). The life cycle of S. 91 
haematobium involves an asexual reproduction phase which occurs in snails of the genus Bulinus, 92 
and the sexual reproduction phase which occurs in human hosts (15). S.haematobium penetrates the 93 
human skin as cercariae and loses its tail and becomes a schistosomulum (16). The schistosomula is 94 
transported to the organs via the venous and lymphatic systems (17). The schistosomula then enter 95 
the lung and pass through the heart on their way to the liver. In the liver, they mature into adult 96 
worms and copulate (18). After copulation females then deposit eggs into the vesicular and pelvis 97 
venous plexus of bladder (19). The eggs then move to lumen of bladder and ureters where they are 98 
eliminated with urine (20).  99 
S. haematobium is known to cause the following morbidity: haematuria, dysuria, hydronephrosis and 100 
bladder wall pathology (1,7,21,22). Due to advances in diagnosis and clinical observation, 101 
schistosomiasis has also been associated with genital morbidity, where in adults, it has been linked to 102 
acquisition of HIV infection (10,16). Genital schistosomiasis manifests differently in males and in 103 
females. In men it manifests as epididymitis which can simulate tuberculosis, hemospermia and 104 
prostatitis (10). In women the symptoms are unspecific, but the most frequent are dyspareunia, 105 
dysmenorrhea, leucorrhea, menstrual disorders, post coital bleeding, cervicitis, endometriosis and 106 
salpingitis. These genital lesions can cause early miscarriages, ectopic pregnancy and infertility (10). 107 
The advanced stage includes bladder calcifications, urinary tract fibrosis, obstructive uropathy and 108 
bladder malignancies (11,17). Of note is that urogenital schistosomiasis has been associated with 109 
increased HIV transmission as it affects the pelvic organs and may also result in abnormal 110 
inflammatory reactions to immunizations (17). S. haematobium has also been associated with 111 
debilitating generalized conditions including malnutrition, anemia, growth retardation, impaired 112 
cognition and developmental delays during childhood (23). 113 
Morbidity is expected to be higher in individuals with high infection intensity (5,21,24–26). To be 114 
specific, children under the age of five have been reported to harbour low infection intensity 115 
which results in difficulties in diagnosis (5,7,8,27). Furthermore with schistosomiasis being 116 
prominent in tropical areas there are many other infectious diseases that schistosomiasis might 117 
mimic (1,28). In this study we demonstrate morbidity associated with S. haematobium in children 118 
under the age of five years old in an endemic district in Zimbabwe and identify clinical morbidity 119 
markers that may be useful in the early diagnosis of schistosomiasis in PSAC.  120 
 121 
Methodology 122 
Study site and design 123 
The study was carried out in Shamva district (31°40′0” E longitude and 17°10′0” S latitude) in 124 
Mashonaland Central province, Zimbabwe (29). Shamva district has the highest prevalence of 125 
schistosomiasis in Zimbabwe at 62.4% (30). It lies 945 m above sea level, the climate is warm and 126 
temperament with an average temperature of 20.2 °C and an annual rainfall of 887 mm. Located in 127 
the Mazowe valley, Shamva district is an area with high farming activity due to its fertile soil. 128 
Residents get their water supply from Mazowe river which spans through the district and is a huge 129 
source of alluvial gold which the vast majority of population survives through panning (29). The 130 
study was a community cross-sectional survey, children were recruited from 19 different villages in 131 
Shamva district gathering at  expanded program for immunisation(EPI) centres and Shamva district 132 
health centres and hospital.  133 
 134 
Study inclusion criteria 135 
The participants recruited in the study had to be aged between 1 to 5 years from the Shamva district 136 
and met the following inclusion criteria: 1. Be lifelong residents of the study area 2. Had no 137 
previous anti-helminthic treatment exposure 3. Parental/guardian consent to participate 4. Be 138 
negative for Schistosoma mansoni and geohelminths  5. Malaria negative 6. Be negative for the 139 
ToRCHeS (toxoplasmosis, rubella, cytomegalovirus, hepatitis and syphilis) screen 7. Be HIV 140 
negative 8. Have a widal TO ratio <1:160. 141 
 142 
Sample size 143 






Where Z is the Z value for the 95% confidence interval, that is alpha = 5% (z = 1.96)  147 
p=proportion/prevalence of the outcome to be investigated (p = 0.62)  148 
q=1-p=0.38  149 
d = precision for the given confidence interval expected expressed as decimal (d=0.05) 150 
n = 363  151 
 152 
Data collection 153 
A questionnaire was administered in the form of history taking done by clinicians to the 154 
caregivers/parents and participants medical records were assessed carefully. In Zimbabwe, 155 
children <5 years old report to health centres once every month for general growth monitoring 156 
which is recorded on growth cards. 157 
 158 
Clinical examinations 159 
The clinical examinations were conducted on  PSAC (n=416)  by three medical practitioners 160 
independent of each other who were blinded to the infection status of the participant. The 161 
examination of the study participants was holistically done according to a standard protocol adopted 162 
from standard clinical practices summarized below(Figure 2) (31,32). 163 
Anthropometry 164 
Height and weight were measured with the participants in light/no clothing. Infantometer baby 165 
board was used to measure height and for weight we used a baby scale. Mid Upper Arm 166 
Circumference (MUAC) : measurement was done on the left arm mid-point between the shoulder 167 
and the elbow tip, with the arm relaxed and hanging down the body. Height and weight for age 168 
charts as well as the MUAC reading were used to assess nutritional status. 169 
 170 
Developmental assessment 171 
We used the childhood developmental charts from UNICEF to measure gross motor, fine motor, 172 
language and social development. 173 
 174 
HEENT(Head, eye, ear, nose and throat)  Examination  175 
Head: Shape, size, masses, fontanelles; amount, colour, texture and distribution of hair; scar and 176 
cleanliness of scalp.  177 
Ears: Tragus or mastoid tenderness, tophi, cerumen, light reflex, bulging, retraction and perforation 178 
of tympanic membrane.  179 
Eye: periorbital oedema, ptosis, lid lag and conjunctival pallor.  180 
Nose: Deformities, deviation and perforation of septum, polyps and unusual discharges . 181 
Mouth and throat: Breath odour; colour, fissures and ulceration of lips; bleeding, ulceration, and lid 182 
line of gums; tooth caries; tongue colour, coating, fissure, papillae atrophy; colour, ulceration, 183 
tumour, monilial patches of buccal mucosa and soft palate; tonsillar inflammation and exudates.  184 
Lymphatic system examination 185 
Lymph nodes: Site, size, consistency, tenderness, fixation, discrete or matted, regional or 186 
generalized enlargement  187 
Respiratory system  188 
Inspection: Cyanosis of lips and nails, clubbing of fingers, rate, depth and character of respiration, 189 
symmetry of shape and expansion, use of accessory muscles, retractions.  190 
Palpation: Tenderness, subcutaneous crepitation, position of trachea, degree of chest expansion (in 191 
cm with tape or hand grip), tactile fremitus.  192 
Percussion: percussion notes (resonance, hyper-resonance, dull, flat), diaphragmatic excursion 193 
Auscultation: Character of breath sounds (vesicular, bronco-vesicular, bronchial, tracheal), crackles, 194 
wheezing, friction rub, vocal resonance.  195 
Cardiovascular system  196 
Arteries: pulse rate, rhythm, volume, character, radio-femoral delay (Carotid, Brachial Radial, 197 
Femoral, Popliteal,  Dorsalis pedis and Posterior tibialis). 198 
Precordium (Heart) examination  199 
Inspection: Presence of precordial bulging, active or quiet precordium, location of apical impulse 200 
(interspace, distance from left midclavicular line)  201 
Palpation: Point of maximal impulse and its character, parasternal heave, thrill, shock Percussion: 202 
cardiac outline (not frequently performed)  203 
Auscultation: 1st and 2nd heart sounds, 3rd and 4th heart sounds, other added heart sounds 204 
(gallop, ejection click, opening snap, pericardial ‘knock’), murmur, friction rub  205 
Abdominal Examination  206 
Inspection: Abdominal symmetry, shape (round, flat, scaphoid), movement with respiration, flank 207 
fullness, everted or inverted umbilicus, dilated vessels, scars, visible peristalsis, presence of hernia 208 
at hernia sites.  209 
Palpation: tenderness (superficial or deep, site), rebound tenderness, guarding and rigidity, 210 
enlarged liver (size in cm below right costal margin along right midclavicular line, consistency, 211 
surface, edge, tenderness), enlarged spleen (size in cm along splenic growth line below left costal 212 
margin, consistency, surface, edge, tenderness, splenic (medial) notch), abdominal mass (size, 213 
consistency, surface, edge, tenderness, fixation, mobility with respiration), and enlarged kidneys 214 
(size, consistency, surface, edge and tenderness by bimanual palpation).  215 
Percussion: Total vertical liver span, liver and splenic dullness, shifting dullness, fluid thrill . 216 
Auscultation: Bowel sounds, bruit over the liver, friction rub over the liver and the spleen, renal 217 
bruit.  218 
Genitourinary system  219 
Costovertebral angle and suprapubic tenderness. In male, scrotum (oedema, hydrocele and hernia), 220 
testes (size and descent), vas deferens (nodules, tenderness), varicocele, urethral orifice 221 
(reddening, discharge, ulcer, phimosis). In females urethral orifice (reddening, discharge), vaginal 222 
discharge, cystocele/rectocele.  223 
Integumentary system 224 
Skin: Texture, rashes, ulcers, urticaria, pigmentation. Hair: texture, Nails: colour, shape (clubbing 225 
and spooning), texture, splinter haemorrhages, capillary refill time.  226 
Musculoskeletal system (Locomotor system)  227 
Muscle: muscle tenderness, spasm. Spine: deformity (kyphosis, scoliosis, kyphoscoliosis), gibbus, 228 
tenderness on percussion or pressure, limitation of movement. Joints: Swelling, tenderness, heat 229 
and redness, crepitus, deformity, limitation of movement on active and passive motions. Bones: 230 
deformity, fracture, tenderness.  231 
Nervous system 232 
Level of consciousness (GCS), orientation in time, place and person; speech disturbance 233 
(dysphasia). 234 
Cranial nerves (CN) one to twelve assessed. 235 
Motor system 236 
Position, bulk, fasciculation (spontaneous or provoked), strength (power), tone, reflex (deep and 237 
superficial)  238 
Deep tendon reflexes 239 
Biceps Triceps supinators Patellar Ankle.  240 
Sensory system  241 
Two point discrimination, Finger-to-nose test, heel-to-shin test, supination-to-pronation of 242 
forearm.  243 
Sample collection 244 
Urine samples were collected by giving the caregiver a wide open container to let the child urinate 245 
in, children 1 year and below used paediatric urine collector attached by a clinician. The caregivers 246 
then brought the samples which were examined. 247 
 248 
Samples processing 249 
Urine samples collected were examined for macrohematuria using the Uristix reagent strips (Uripath, 250 
Plasmatec, UK) dipped into fresh, well-mixed urine for 40 sec and the test area was compared with a 251 
standard colour chart as per manufacturer’s instructions. The parasitology team conducted 252 
parasitology examination and results were recorded separately, not accessed by the clinical team. 253 
Approximately 50 ml of urine sample was collected from each participant on three consecutive days. 254 
The samples were collected between 10am and 2pm and processed within 2 hours of collection by 255 
urine filtration method and were examined using microscopy for S. haematobium eggs detection. The 256 
number of eggs were reported per 10ml of urine. Stool samples were collected on a single day and 257 
processed using the Kato Katz method with 2 slides prepared per sample, parasite eggs were 258 
enumerated under a light microscope for  S.mansoni in duplicate per gram of stool. A formal ether 259 
sedimentation technique was used to test for geohelminths presence (33). 260 
 261 
Plasma and sera were obtained from blood collected in well-labeled EDTA and coagulant-free blood 262 
collection tubes respectively. Samples  from each child were processed  and tested for 263 
toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus 1 and 2, HIV and hepatitis. The sera 264 
was processed using the Maglumi 4000 chemiluminescence immunoassay analyser (CLIA). Children 265 
noted to have infection were managed appropriately by the doctors in the study and the 266 
community nurse. Thick blood film slides were stained using the Geimsa stain and examined for 267 
malaria parasites using microscopy. 268 
 269 
Ethical statement 270 
Ethical approval was obtained from Medical Research Council of Zimbabwe (MRCZ/A/2435). 271 
Gatekeeper approval  was obtained from the Provincial and District Medical Directors and  272 
Community Leaders. Informed consent was obtained from the parents or guardians of the children. 273 
All participants with confirmed infection were offered  treatment.  274 
 275 
Statistical method 276 
Data analysis was performed using STATA version 15.  The statistical methods applied included the 277 
descriptive statistics, bivariate analysis using odds ratio and multivariate logistic regression 278 
modelling. In this study we determined how much of the detected morbidity was attributable to S. 279 
haematobium infection by elucidating Prevalence Ratios (PRs). The morbidity markers were selected 280 
based on them having a PR>1, which shows a significant association with S. haematobium infection. 281 
The multivariate logistic regression models were fitted to adjust for potential confounding factors for 282 
the five manifestations with three explanatory variables;  that is sex, age and schistosomiasis 283 
infection. The effect of different factors on the prevalence of schistosome infection and morbidity 284 
was determined using logistic regression and the results reported as adjusted ORs (AORs) and 95% 285 
confidence interval (CI), along with the test for significance, as previously described (34). Infection 286 
intensity for S. haematobium was defined as the arithmetic mean egg count/10ml of at least two urine 287 




A total of 416 children from 19 villages in Shamva district, Mashonaland central in Zimbabwe were 292 
included into the study (Figure 1). The number of males was 214 (51.4%) and the difference in sex 293 
composition was not statistically significant (p=0.20). Age was normally distributed (Shapiro Wilk 294 
test, p=0.068) and the range [min-max] was [1-5] years with mean ± (SD) age of 3.39 ±1.08years.  295 
 296 
Morbidity observed in the study participants 297 
Clinical features observed in the study participants were as follows: 8% (36) had hematuria, 36% 298 
(149) had inguinal lymphadenopathy, 19% (81) had ascites, 19% (79) had wheezes, 11% (46) had 299 
shortness of breath, 4% (20) had an atopy history, 10% (43) had malnutrition and 18% (75) had 300 
stunting  301 
(Table 1).  302 
 303 
S. haematobium epidemiology 304 
The overall S.haematobium infection prevalence was 35.1% (146).  When segregated by sex, 305 
schistosomiasis prevalence was higher in females 37.1% (75/212) were positive compared to males 306 
with a prevalence of 33.2% (71/214).  A greater proportion of females were infected at the ages of 2, 307 
3 and 4 years with more males being infected at 1 year and 5 years. The likelihood of developing 308 
schistosomiasis increased with age (Figure 3). 309 
 310 
Characterizing Schistosomiasis Morbidity in Children under the Age of Five Years 311 
Children with S. haematobium were at greater odds of presenting with the following: haematuria 312 
(Adjusted Odds Ratio (AOR) = 12.6 95%CI 11.6 to 14.1), inguinal lymphadenopathy (AOR = 99.2 313 
(95%CI 24.2 to 854.5), Ascites (AOR=23.9 ( 95%CI 11.4 to 54), wheezes (AOR = 35.4 (1.72 314 
(95%CI 15.3 to 94.2), shortness of breath (AOR = 1.72(95%CI 0.87 to 3.35), atopy history AOR = 315 
5.6 (95%CI 1.85 to 20.2), malnutrition (using weight for age and height for age charts) AOR = 316 
1.8(95%CI 1.3 to 3.2), malnutrition (using MUAC tape) AOR = 2.3 (95%CI 1.4 to 3.2) and stunting 317 
(AOR = 1.9 (95%CI 1.1 to 2.2) (Table 2). 318 
 319 
Morbidity attributable to S.haematobium was noted to be high for Inguinal lymphadenopathy ( 320 
Attributable Fraction (AF) = 68.4% (95%CI 65.9 to 70.2), haematuria (AF = 92.6% (90.5 to 95.3), 321 
ascites (AF = 91.5% (95%CI 88.5 to 94.9), wheezes (AF = 93.9% (95% CI 90.1 to 96.2), shortness 322 
of breath (AF = 35.9 (95%CI 31.2 to 36.8), Atopy history (AF = 76.9 (95%CI 75.2 to 78.5), 323 
malnutrition(using MUAC tape) (AF = 20% 95%CI 10 to 40) malnutrition (using weight for age and 324 
height for age chats) AOF = 20% 95%CI 10 to 40), Stunting (AF = 38.2 (95%CI 16.7 to 61%)) 325 
(Table 3). 326 
 327 
The inguinal lymph nodes observed were rubbery, immobile, non-tender and >2cm in size. A 328 
relationship indicating that an increase in schistosomiasis infection is associated with a 329 
corresponding increase in inguinal lymphadenopathy prevalence in children who were 330 
S.haematobium infected was observed at each area (site) (Figure 4). An association between the 331 
likelihood of lymphadenopathy and the likelihood of schistosomiasis infection was also proven 332 




To our knowledge, this is the first study reporting on different morbidity markers associated with S 337 
haematobium infections in PSAC. We found a positive association between S. haematobium 338 
infection with the following: inguinal lymphadenopathy, wheezes and crackles, ascites, an atopy 339 
history, haematuria and nutritional status.  Inguinal lymphadenopathy, wheezes, ascites and atopy 340 
history have not been previously noted as S. haematobium morbidity markers.  341 
 342 
To our knowledge this is the first study to identify the strong association between schistosomiasis 343 
and inguinal lymphadenopathy. There was a five-fold higher odds of having Schistosomiases among 344 
those who presented with inguinal lymphadenopathy than among those without the infection. Most 345 
of the other common causes of lymphadenopathy (35) (including tuberculosis and HIV) in the 346 
population were excluded, strengthening confidence in our findings. In a study in Zimbabwe among 347 
the general population, 4% of the lymph node samples had non-tuberculous inflammatory changes. 348 
Most of the nodes were from patients aged one to fifteen years in rural hospitals. In literature, S. 349 
haematobium has not been linked to lymphadenopathy, though S. mansoni and S. japonicum  have 350 
been recorded to cause enlarged abdominal lymph nodes (36–38). We present novel findings to 351 
suggest that this may have been partly due to schistosomiasis (35). Involvement of regional lymph 352 
nodes in schistosomiasis infected mice have been noted in S. mansoni infection (36). The association 353 
of inguinal lymphadenopathy with S. haematobium requires further investigation on the 354 
immunopathological manifestation. 355 
 356 
The lungs have not previously been understood to be an end organ of schistosomiasis morbidity 357 
manifestation (2,39,40). We found strong associations between S. haematobium infection and 358 
respiratory morbidity among PSAC. S. haematobium infected children had wheezes and crackles in 359 
the chest on auscultation, with a 35-fold higher odds of respiratory morbidity.  Acute schistosomiasis 360 
is known to present as shortness of breath, wheezing, and a dry cough and is said to happen in 361 
Schistosoma naïve travellers (41) Similar findings in children from an endemic area suggest 362 
comparable immunological naivety. Chest X-rays of people with pulmonary schistosomiasis show a 363 
milliary mottling resembling milliary tuberculosis or midzone infiltrates and condensed basilar zones 364 
(28). In areas like Zimbabwe, where schistosomiasis is endemic,  TB is also prevalent making a 365 
diagnosis of pulmonary schistosomiasis difficult as clinicians are more likely to diagnose TB than 366 
neglected tropical diseases (28). In our study TB was an exclusion criterion. Our finding makes it 367 
crucial for clinicians and policymakers to be alerted, as this has the capacity of reducing under-fives 368 
morbidity vastly thus improving their quality of life. 369 
 370 
  371 
S.haematobium is not previously correlated to abdominal morbidity, in our study we found an 372 
attributable fraction of 91.5 % with a PR of 11.8 to ascites in schistosomiasis positive PSAC. The 373 
odds ratio of the positive children presenting with abdominal distension and ascites was noted to be 374 
21.9 (95% CI 10.9 to 44) with a p-value of <0.001) For the first time we have demonstrated ascites 375 
in S. haematobium infected children without S.mansoni or geohelminths as co-infections, or any 376 
other possible causes of ascites after a thorough work up. Furthermore, the children were treated by a 377 
single dose of praziquantel (at 20mg/kg) and on follow-up the ascites had resolved without any 378 
further intervention. The infected individuals started with what appeared like a pot belly as in Figure 379 
6. Further follow up with an ultrasound scan would be beneficial and further bio-chemical evaluation 380 
of the ascitic fluid would be very valuable. 381 
 382 
Contrary to previous reports of an inverse relationship between schistosomiasis and atopy, infected 383 
children had a 6-fold higher odds of presenting with atopy (6,42,43). It has been reported that 384 
schistosomiasis in PSAC is usually at low intensities and this might explain why we had a positive 385 
relation (5). Further immunological studies are necessary to understand the higher odds ratio we 386 
reported. 387 
 388 
Our study provided additional evidence of the relationship between schistosomiasis and haematuria 389 
(7,16,18,20,34). The observed haematuria is secondary to eggs being lodged in the bladder wall. 390 
However, due to low intensity of infection in the PSAC, macrohematuria is not often detected by the 391 
caregiver that makes the health seeking habits due to S. haematobium in this age group very poor 392 
(34). We recommend that caregivers and medical professions in endemic areas be made aware of the 393 
other signs and symptoms to look out for in infected PSAC, in-order to avoid this bias. 394 
 395 
Nutritional status has been shown to be affected by S. haematobium status in PSAC and even in 396 
SAC. The process starts in the womb during pregnancy, infected mothers expose their foetuses to 397 
chronic inflammation which may result in low birth weight babies (13). After birth the baby is still 398 
exposed to inflammatory markers and once the baby can sit they become exposed to contaminated 399 
water when the caregiver takes them to a water source whilst doing house chores (13,27). Chronic 400 
exposure to inflammatory markers has been associated with malnutrition (44). In this study we report 401 
that malnutrition and stunting had the lowest attributable factors even though they are the most 402 
frequently described in association with schistosomiasis morbidity (1,5,8,15,22,27,42). 403 
 404 
The strength of this study included the fact that although the calculated sample size was 368, we 405 
managed to enrol 416 participants. We were also able to exclude other major endemic conditions 406 
from the area, increasing the likelihood that the morbidities were due to S. haematobium. While there 407 
is a small chance that some excluded conditions were actually false negatives, we followed study 408 
protocol, repeating all tests at least twice. Another limitation is that we only excluded the main 409 
known endemic conditions in the area, and there is a chance that some participants had other 410 
infection altogether.  This is unlikely as the white cell count and C-reactive proteins in all 411 
S.haematobium negative enrolled participants were within the normal ranges.  412 
 413 
Conclusion  414 
To achieve the 2025 goal of eliminating schistosomiasis, there is an urgent need for early 415 
schistosomiasis diagnosis. The morbidity markers described in this paper can be used to increase the 416 
index of S. haematobium suspicion in PSAC within endemic areas. In this study it was found that S. 417 
haematobium in PSAC contrary to popular belief does not only affect the genitourinary system. For 418 
the first time it was noted that it also affects the respiratory, gastrointestinal and lymphatic system. 419 
An interesting relationship was noted between Schistosomiasis and atopy. It is important that 420 
clinicians in schistosomiasis endemic areas be alerted of these morbidity markers of S. haematobium 421 
in order to increase indices suspicion for schistosomiasis in pre-school age children. 422 
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Table 1: Distribution of clinical morbidities in pre-school aged children(1-5 years old).  550 
Clinical Features Schistosomiasis Infection 
(eggs in urine) Status 
Totals 
% (n) 
Infected  Not infected  
 Haematuria Positive 24 12  9% (36) 
Negative 122 258 91% (380) 
Inguinal 
lymphadenopathy 
Present  95 54 36% (149) 
Absent 52 215 64% (267) 
Ascites  Present 71 10 19% (81) 
Absent 76 259 81% (335) 
Sounds in the chest wheezes 72 7 19% (79) 
Clear 75 262 81% (337) 
Respiratory rate Shortness of 
breath 
22 24 11% (46) 
Normal 125 245 89% (370) 
Atopy History Yes 15 5 5% (20) 
No 132 264 95% (396) 
Malnutrition 
(weight and height for age 
chats) 
Yes  17 17 8% (34) 
No  123 259 92% (382) 
Malnutrition 
(MUAC) 
Yes  5 4 2% (9) 
No  174 233 98% (407) 
Stunting Yes  38 37 18% (75) 
No  71 270 82% (341) 














95% Confidence Interval 
 Haematuria 21.8* (11.7- 40.7) 
Inguinal lymphadenopathy 4.63* (2.21-5.96) 
























Malnutrition (weight and 










*Significant at 5% level of significance (p=<0.05) 561 
 562 
Table 3: Morbidity Attributable to S. haematobium infection 563 




Palpation in the 
lymph nodes area 
3.16 (2.34-4.56) 68.4 (65.9-70.2) 
Haematuria  Urine dipsticks 12.6 (11.4-14.1) 92.6 (90.5-95.3) 
Distended Abdomen 
with shifting 











16.4 (13.5-20) 93.9 (90.1-96.2) 
Tachypnoea with 
shortness of breath 
Observation and 
respiratory rate 
1.56 (1.02-3.11) 35.9 (31.2-36.8) 
Atopy History Questionnaire  4.32 (3.67-6.89) 76.9 (75.2-78.5) 
Malnutrition 
(MUAC) 
MUAC tape 1.2 (0.7-1.9) 20 (10-40) 
Malnutrition (WHZ) Weight for height 
WHO child growth 
charts 
1.0 (0.8-1.4) 5 (0.0-40) 
Stunting  Height for age from 
WHO child growth 
charts 







Figure 1: Flow diagram showing the selection steps of the study population and the exclusion criteria 570 
 571 
n=1368
children under five years who 




non lifelong residence of Shamva
n=36




had coinfection with S. mansoni, 
geohelminths or had an acute 
illness in progress
n=50
mantoux test >5mm reactive
n=320 
Positive for any ToRCHeS 
infection or positive for 
salmonella typhi
n=15





Figure 2: Showing the methodology protocol used for the systematic examinations conducted by the 575 
3 clinical members independent of each other and without the knowledge of parasitology diagnostic 576 






Participants were assessed for jaundice, 
anemia, cyanosis, clubbing, oedema 
lymphadenopathy, hydration and nutritional 
status, skin changes and scars
Cardiovascular system
Assess peripheral and central pulse
locate the apex beat and trachea 
position.
auscultation for heart sounds and 
murmurs
Respiratory system
inspecction of the 







auscultation of the 
chest to assess 
quality of breath 
sounds, vocal 
resonance and 
presence of added 
sounds
Gastro-urinary system
inspection for abdominal distension, 
masse,s scars,  excoriation, pulsation, striae, 
capot medusae, abnormalities in the genital 
region.
palpation: tenderness, guarding 
organomegally, testes
auscultation for bowel sounds and bruits
Anthropometry
height and weight were 
measured with the 
participants in light/no 
clothing.
infantometer baby board 
was used to measure height 
and for weight we used a 
baby scale.
MUAC: measurement was 
done on the left arm mid-
point between the shoulder 
and the elbow tip, with the 
arm relaxed and hanging 
down the body.
height and weight for age 









gibbus, tenderness on 




heat and redness, 
crepitus, deformity, 
limitation of 
movement on active 




we assessed the 12 
cranial nerves, 
inspected both the 
upper and lower limbs 
for deformities, scars. 
tested reflexes across all 
joint and  power across 
all muscle groups
 581 






Figure 4:  The association between schistosomiasis prevalence and inguinal lymphadenopathy prevalence 588 












































Figure 6: A 4 year old child with S. haematobium infection with no S.mansoni infestation. 603 
 604 
